Boule Diagnostics Logo

Boule Diagnostics

Provider of hematology systems for decentralized human and veterinary markets.

BOUL | ST

Overview

Corporate Details

ISIN(s):
SE0011231158
LEI:
213800IK1TGY858TKZ45
Country:
Sweden
Address:
DOMNARVSGATAN 4, 163 53 SPÅNGA

Description

Boule Diagnostics is a global provider of diagnostic solutions specializing in hematology. The company develops, manufactures, and markets systems and consumables for blood diagnostics, including hematology analyzers, clinical chemistry analyzers, and associated reagents, controls, and calibrators. Its products are tailored for decentralized healthcare settings in both the human and veterinary markets, such as smaller laboratories and clinics. The company aims to enhance global healthcare access by providing high-quality instruments that deliver timely and accurate blood test results.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-05 08:25
Boule Diagnostics meddelar att VD lämnar och organisationen förbereder sig för …
Swedish 83.7 KB
2025-12-05 08:25
Boule Diagnostics Announces CEO Transition as Organization Prepares for Next Ch…
English 83.6 KB
2025-11-21 16:00
Boule Diagnostics – Nomination Committee for the Annual General Meeting 2026
English 78.2 KB
2025-11-21 16:00
Boule Diagnostics – Valberedning inför årsstämman 2026
Swedish 77.9 KB
2025-10-29 11:19 Swedish 10.0 KB
2025-10-24 08:00 Swedish 477.6 KB
2025-10-24 08:00 English 480.3 KB
2025-10-13 08:35
Boule Diagnostics CFO lämnar för ny möjlighet
Swedish 54.9 KB
2025-10-13 08:35
Boule Diagnostics Announces CFO Departure for New Opportunity
English 55.8 KB
2025-07-21 10:20 Swedish 10.5 KB
2025-07-18 12:43 Swedish 10.5 KB
2025-07-18 08:00 Swedish 561.0 KB
2025-07-18 08:00 English 549.3 KB
2025-05-07 17:45
Kommuniké från Boule Diagnostics årsstämma den 7 maj 2025
Swedish 49.2 KB
2025-05-07 17:45
Bulletin from the Annual General Meeting May 7, 2025 in Boule Diagnostics
English 49.6 KB

Automate Your Workflow. Get a real-time feed of all Boule Diagnostics filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Boule Diagnostics

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Boule Diagnostics via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-10-30 Emil Hjalmarsson Other Buy 900,000 6,408,000.00 SEK
2024-10-30 Torben Jörgensen Other Buy 100,000 712,000.00 SEK
2024-10-30 Emil Hjalmarsson Other Buy 65,000 462,800.00 SEK
2023-05-15 Torben Jörgensen Other Buy 5,000 54,000.00 SEK
2023-05-03 Torben Jörgensen Other Buy 10,000 120,000.00 SEK
2023-04-03 Torben Jörgensen Other Buy 5,000 60,000.00 SEK
2023-02-27 Jan Benjaminson Other Buy 8,000 102,000.00 SEK
2023-02-03 Yvonne Mårtensson Other Buy 7,083 100,224.45 SEK
2022-12-16 Jesper Söderqvist Other Buy 2,678 34,680.10 SEK
2022-12-15 Jesper Söderqvist Other Buy 55,034 706,086.22 SEK

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.